Cardiac enzymes are essential indicators in the assessment of heart health, providing valuable insights into cardiac conditions. These enzymes, including myoglobin, creatine kinase-MB (CK-MB), and aspartate aminotransferase (AST), serve as sensitive markers for myocardial damage. Elevated levels of these enzymes in the bloodstream can signal various cardiac issues, such as myocardial infarction or angina. Among them, CK-MB is particularly specific to heart muscle, aiding in the accurate diagnosis of heart-related disorders. The measurement and interpretation of cardiac enzyme levels empower healthcare professionals to make informed decisions, facilitating early detection and intervention in cardiac emergencies. Understanding the nuances of different cardiac enzymes enhances the precision of cardiovascular diagnostics, contributing to more effective patient care.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation